Table 4:

Point Prevalent Abstinence and Postcessation Weight Gain for the Three Latent Profiles

	LP1, Typically Concerned (n = 180)		LP2, Minimally Concerned (n = 114)		LP3, Highly Concerned (n = 49)
Point prevalent abstinence	%	n	%	n	%	n
3-months	32%	63	31%	35	25%	12
6-months	23%	41	28%	32	16%	8
12-months	24%	43	24%	27	10%	5
LP2 v. LP1	F or t	p	OR
Overall	0.10	0.753
3-months	1.06	0.291	1.33
6-months	−0.76	0.445	0.81
12-months	0.30	0.762	1.09
LP3 v. LP1	F or t	p	OR
Overall	7.23	0.008
3-months	1.46	0.145	1.74
6-months	1.04	0.300	1.57
12-months	2.09	0.037	2.93
	LP1, Typically Concerned (n = 180)			LP2, Minimally Concerned (n = 114)			LP3, Highly Concerned (n = 49)
Postcessation weight gain*	Mean	SD	n	Mean	SD	n	Mean	SD	n
3-months	4.67	6.11	49	5.39	4.41	28	6.61	8.00	8
6-months	7.08	7.99	38	6.88	8.33	29	13.09	7.93	5
12-months	6.60	10.68	41	10.75	10.85	25	15.44	16.16	5
LP2 v. LP1	F or t	p		Estimate
Overall	0.52	0.473
3-months	0.13	0.898		0.26
6-months	0.30	0.762		0.63
12-months	1.92	0.058		3.98
LP3 v. LP1	F or t	p		Estimate
Overall	3.10	0.081
3-months	1.11	0.268		3.46
6-months	1.71	0.090		6.18
12-months	1.94	0.055		7.15

Note. LP = latent profile; SD = standard deviation. OR = odds ratio.

^*Only examined among women who were abstinent, of whom some did not provide weight information. Weight is presented in pounds. Treatment condition was included as a covariate in all models. Precessation weight was included as a covariate in postcessation weight gain models.